Other Disorders of Multiple Glycosylation Pathways

This grouping collects rare inherited glycosylation disorders in which the primary lesion is not a single canonical N-glycan assembly enzyme or Golgi processing enzyme, but instead affects nucleotide-sugar precursor supply or ER glycoprotein quality control with consequences across multiple glycan or glycoprotein pathways. The work-package members are UGDH-related DEE84, UGP2-related DEE83, and UGGT1-CDG.

Shared Pathway

Why this grouping

These entries are kept as separate Disease entries because their proximal lesions are distinct: UGDH limits UDP-glucuronic acid supply for glycosaminoglycan/proteoglycan and glycolipid production; UGP2 limits UDP-glucose-dependent glycogen and protein glycosylation biology in brain; and UGGT1 disrupts ER reglucosylation-based quality control of N-linked glycoproteins. They are grouped only at the pathway-placement level as "other/multiple glycosylation pathway" disorders rather than merged into a single disease entity.

Membership criteria

NECESSARY  (member ⇒ criteria)
A member has a primary lesion in a nucleotide-sugar precursor pathway, glycosaminoglycan/proteoglycan biosynthesis, or ER N-glycoprotein quality control that affects more than one downstream glycan or glycoprotein client class.

Coverage and gaps

3 rows 1 contradiction Exact MONDO scope not assessed 3 listed with MONDO ID

No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.

Status DisMech entry MONDO concept In DisMech Has MONDO ID In grouping MONDO Member state Conditions satisfied C1.1 Impairs glycosaminoglycan biosynthesis. GO:0006024 C1.2 Impairs protein O-linked glycosylation. GO:0006493 C1.3 Perturbs protein N-linked glycosylation. GO:0006487 C1.4 Perturbs ER protein-folding quality control. GO:0034975
listed with MONDO ID
UGGT1-congenital disorder of glycosylation DISEASE
Differentiating mechanism
UGGT1 variants impair reglucosylation and ER retention of the UDP-glucose:glycoprotein glucosyltransferase quality-control enzyme for N-linked glycoproteins. UGGT1 hgnc:15663protein folding in endoplasmic reticulum GO:0034975
UGGT1-congenital disorder of glycosylation
MONDO:0980705
yes yes not assessed listed satisfied NOT SATISFIED NOT SATISFIED SATISFIED SATISFIED
listed with MONDO ID
UGP2-related developmental and epileptic encephalopathy 83 DISEASE
Differentiating mechanism
UGP2 short-isoform loss in brain reduces UDP-glucose production in neural stem cells, affecting glycogen metabolism, glycosylation, and ER proteostasis. UGP2 hgnc:12527protein N-linked glycosylation GO:0006487
developmental and epileptic encephalopathy, 83
MONDO:0032895
yes yes not assessed listed contradiction NOT SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED
listed with MONDO ID
UGDH-related developmental and epileptic encephalopathy 84 DISEASE
Differentiating mechanism
UGDH loss reduces conversion of UDP-glucose to UDP-glucuronic acid, limiting precursor supply for glycosaminoglycan-rich proteoglycans and glycolipids. UGDH hgnc:12525glycosaminoglycan biosynthetic process GO:0006024
developmental and epileptic encephalopathy, 84
MONDO:0032918
yes yes not assessed listed satisfied SATISFIED NOT SATISFIED NOT SATISFIED NOT SATISFIED

Source

View YAML on GitHub
Raw YAML
name: Other Disorders of Multiple Glycosylation Pathways
display_name: Other Disorders of Multiple Glycosylation Pathways
creation_date: "2026-07-06T06:04:18Z"
description: >-
  This grouping collects rare inherited glycosylation disorders in which the
  primary lesion is not a single canonical N-glycan assembly enzyme or Golgi
  processing enzyme, but instead affects nucleotide-sugar precursor supply or
  ER glycoprotein quality control with consequences across multiple glycan or
  glycoprotein pathways. The work-package members are UGDH-related DEE84,
  UGP2-related DEE83, and UGGT1-CDG.
grouping_basis:
- SHARED_PATHWAY
grouping_rationale: >-
  These entries are kept as separate Disease entries because their proximal
  lesions are distinct: UGDH limits UDP-glucuronic acid supply for
  glycosaminoglycan/proteoglycan and glycolipid production; UGP2 limits
  UDP-glucose-dependent glycogen and protein glycosylation biology in brain;
  and UGGT1 disrupts ER reglucosylation-based quality control of N-linked
  glycoproteins. They are grouped only at the pathway-placement level as
  "other/multiple glycosylation pathway" disorders rather than merged into a
  single disease entity.
membership_criteria:
- description: >-
    A member has a primary lesion in a nucleotide-sugar precursor pathway,
    glycosaminoglycan/proteoglycan biosynthesis, or ER N-glycoprotein quality
    control that affects more than one downstream glycan or glycoprotein client
    class.
  criteria_semantics: NECESSARY
  logic:
    operator: OR
    description: >-
      Multiple-pathway glycosylation defects represented by precursor supply,
      glycosaminoglycan biosynthesis, N-linked glycosylation, or ER folding
      quality control.
    operands:
    - criterion_predicate: HAS_BIOLOGICAL_PROCESS
      description: Impairs glycosaminoglycan biosynthesis.
      biological_processes:
      - preferred_term: glycosaminoglycan biosynthetic process
        term:
          id: GO:0006024
          label: glycosaminoglycan biosynthetic process
    - criterion_predicate: HAS_BIOLOGICAL_PROCESS
      description: Impairs protein O-linked glycosylation.
      biological_processes:
      - preferred_term: protein O-linked glycosylation
        term:
          id: GO:0006493
          label: protein O-linked glycosylation
    - criterion_predicate: HAS_BIOLOGICAL_PROCESS
      description: Perturbs protein N-linked glycosylation.
      biological_processes:
      - preferred_term: protein N-linked glycosylation
        term:
          id: GO:0006487
          label: protein N-linked glycosylation
    - criterion_predicate: HAS_BIOLOGICAL_PROCESS
      description: Perturbs ER protein-folding quality control.
      biological_processes:
      - preferred_term: protein folding in endoplasmic reticulum
        term:
          id: GO:0034975
          label: protein folding in endoplasmic reticulum
members:
- member: UGDH-related developmental and epileptic encephalopathy 84
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      UGDH loss reduces conversion of UDP-glucose to UDP-glucuronic acid,
      limiting precursor supply for glycosaminoglycan-rich proteoglycans and
      glycolipids.
    gene:
      preferred_term: UGDH
      term:
        id: hgnc:12525
        label: UGDH
    biological_processes:
    - preferred_term: glycosaminoglycan biosynthetic process
      modifier: DECREASED
      term:
        id: GO:0006024
        label: glycosaminoglycan biosynthetic process
- member: UGP2-related developmental and epileptic encephalopathy 83
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      UGP2 short-isoform loss in brain reduces UDP-glucose production in neural
      stem cells, affecting glycogen metabolism, glycosylation, and ER
      proteostasis.
    gene:
      preferred_term: UGP2
      term:
        id: hgnc:12527
        label: UGP2
    biological_processes:
    - preferred_term: protein N-linked glycosylation
      modifier: ABNORMAL
      term:
        id: GO:0006487
        label: protein N-linked glycosylation
- member: UGGT1-congenital disorder of glycosylation
  member_type: DISEASE
  differentiating_mechanisms:
  - description: >-
      UGGT1 variants impair reglucosylation and ER retention of the
      UDP-glucose:glycoprotein glucosyltransferase quality-control enzyme for
      N-linked glycoproteins.
    gene:
      preferred_term: UGGT1
      term:
        id: hgnc:15663
        label: UGGT1
    biological_processes:
    - preferred_term: protein folding in endoplasmic reticulum
      modifier: ABNORMAL
      term:
        id: GO:0034975
        label: protein folding in endoplasmic reticulum
notes: >-
  This is an auditable work-package subgroup, not an attempt to replace the
  broader Congenital Disorders of Glycosylation grouping or the MONDO hierarchy.